Torigen Pharmaceuticals, Inc.
Cell & Genome Science Building R1855 CB129
400 Farmington Ave.
Farmington, CT 06032
Ashley Kalinauskas, CEO – A.Kalinauskas@vetivax.com
Torigen Pharmaceuticals, Inc. is focused on providing veterinary cancer care solutions for companion animals. Our novel, personalized immunotherapy uses the animals’ existing tumor cells to fight cancer. When combined with an innovative bulking agent, MIM™ (matrix immune modulator), an overall reduction in tumor size and inhibition of metastasis has been observed throughout multiple peer-reviewed publications. This is the basis and foundation for Torigen’s personalized veterinary cancer treatment, VetiVax.
Personalized cancer immunotherapies for the veterinary market. Have completed extensive safety trials and are continuing to gather efficacy data.